In early October, FCB Health Network proudly launched #WhyVote, a non-partisan campaign that uses the power of storytelling to inspire and empower Americans to vote. On October 30, FCB Health Network partnered with Black Rock Coalition and Club House Global to host the apex of the #WhyVote initiative’s 2020 efforts: #WhyVote Live – A Virtual Pep Rally to the Polls.
GlaxoSmithKline and Sanofi struck a $2.1 billion deal with the U.S. government’s Operation Warp Speed program to supply an initial 100 million doses of a Covid-19 vaccine candidate under development by the two companies.
The Coalition for Epidemic Preparedness Innovation (CEPI) plans to have two or three manufacturing plants for each vaccine, James Robinson, a longtime biopharma executive leading CEPI’S vast manufacturing push, said in an interview.
French drugmaker Sanofi SA expects to get approval for the potential COVID-19 vaccine in development with Britain’s GlaxoSmithKline Plc by the first half of 2021, faster than previously anticipated.
San Diego-based Neurocrine Biosciences is partnering with Japan’s Takeda Pharmaceutical to develop and commercialize molecules in Takeda’s early-to-mid-stage psychiatry pipeline.
Shares of Denmark-based Genmab climbed after the company announced a broad oncology alliance with AbbVie that is valued at close to $4 billion, one of the largest oncology partnerships in the industry.
A summary of daily biopharma industry news regarding the novel coronavirus trending on March 27, 2020, with the FDA now working with 220 test developers.
Fingerpaint – a national full-service health and wellness marketing agency – in partnership with The Alliance for Positive Health, launched a provocative campaign aimed at bringing awareness to the alarming increase of sexually transmitted infections across the country.